Previously Disclosed

Related by string. * previ ously . PREVIOUSLY . pre viously . previously : previously undetectable steroid . #.#/# previously . previously unreleased songs . previously unreleased recordings / Disclosing . disclosed . discloser . DISCLOSED : disclosed Plame identity . disclosing confidential . disclosing Plame identity . Microsoft Vulnerabilities Disclosed * discloser previously disclosed *

Related by context. Frequent words. (Click for all words.) 74 Share Repurchases 72 Annual Meeting Date 72 Explore Strategic Alternatives 72 Completes Tender Offer 72 FY# Guidance 71 Previously Announced 71 Extends Tender Offer 71 Provides Guidance 71 Issues Guidance 70 Guidance Quick Facts 70 Record Second Quarter 70 #.#/Share [002] 70 Forecast Quick Facts 70 Patient Enrollment 69 Option Grants 69 Regains Compliance 69 Shelf Registration Statement 68 Q2 Loss Narrows 68 Stock Buyback 68 Updates Guidance 68 Guides Q2 68 Offering Quick Facts 68 Files Annual Report 68 Q4 Loss Narrows 68 Cash Tender Offers 68 4Q Loss Widens 68 Q1 Loss Narrows 68 Stock Repurchase 68 Reaffirms Guidance 68 Lowers Guidance 67 Revenues Decline 67 CFO Resigns 67 Q1 Loss Widens 67 Guides Q4 67 Shareholder Vote 67 Buyout Offer 67 Guides FY# 67 Announces Definitive Agreement 67 Increases Quarterly Cash Dividend 67 Drug Candidate 67 Q4 Loss Widens 67 Q3 Loss Narrows 67 Goldfarb Branham Law Firm 67 Record Third Quarter 67 Stockholders Approve Merger 67 Q2 Loss Widens 67 Provides Updates 67 1st Quarter Results 67 Shareholder Letter 67 Q3 Profit Surges 67 Dividend Increase 67 Share Buyback 67 Posts Wider Loss 66 2nd Quarter Results 66 Patent Lawsuit 66 Q2 Profit Surges 66 Below Estimates 66 Q4 Profit Surges 66 3rd Quarter Results 66 Smallpox Vaccine 66 Guides Q3 66 Nine Month 66 Lifts FY# EPS 66 Vertex Pharmaceuticals Announces 66 L.P. 66 Related Costs 66 Director Shareholding 66 FDA Accepts 66 Equity Stake 66 Shareholder Investigation 65 Announces Organizational Changes 65 Below Consensus 65 Cholesterol Drug 65 Raises Guidance 65 Commences Tender Offer 65 Q3 Loss Widens 65 Preliminary Fourth Quarter 65 Declares Quarterly Dividends 65 Generic Version 65 Updates Status 65 Above Estimates 65 Extends Offer 65 Issues Statement Regarding 65 EPS Guidance 65 Action Lawsuits 65 Boosts Dividend 65 Analyst Upgrade 65 Prostate Cancer Patients 65 Provides Preliminary 65 Q1 Profit Declines 65 Net Loss Narrows 65 1Q Loss 64 Raises PT 64 Mln Shares 64 Shareholders Approve Merger 64 Guides Q1 64 Announce Completion 64 Cent Dividend 64 Restates 64 Announces Revised 64 Announces Share Repurchase

Back to home page